Rose Jean-mary
Visit Investigator ProfileInvestigation Details
Detailed Analysis
Jean-mary employs a diligent and meticulous approach during audits. She focuses on contamination prevention measures and quality of materials in drug formulation. She is stringent about the necessity of pharmaceutical-grade components and rigorous cleaning procedures to avoid cross-contamination.
FDA auditor Rose Jean-mary appears to be particularly concerned about drug compounding and the standards of components used in drug formulations. She shows a predilection for addressing contamination and cross-contamination. Jean-mary is distinguished by her strict insistence on the use of pharmaceutical-grade components in the formulation of non-sterile drug products.
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies